Tekla Healthcare Opportunities Fund Paid Distribution

Editorial & Advertiser Disclosure Global Banking And Finance Review is an independent publisher which offers News, information, Analysis, Opinion, Press Releases, Reviews, Research reports covering various economies, industries, products, services and companies. The content available on globalbankingandfinance.com is sourced by a mixture of different methods which is not limited to content produced and supplied by various staff writers, journalists, freelancers, individuals, organizations, companies, PR agencies Sponsored Posts etc. The information available on this website is purely for educational and informational purposes only. We cannot guarantee the accuracy or applicability of any of the information provided at globalbankingandfinance.com with respect to your individual or personal circumstances. Please seek professional advice from a qualified professional before making any financial decisions. Globalbankingandfinance.com also links to various third party websites and we cannot guarantee the accuracy or applicability of the information provided by third party websites. Links from various articles on our site to third party websites are a mixture of non-sponsored links and sponsored links. Only a very small fraction of the links which point to external websites are affiliate links. Some of the links which you may click on our website may link to various products and services from our partners who may compensate us if you buy a service or product or fill a form or install an app. This will not incur additional cost to you. A very few articles on our website are sponsored posts or paid advertorials. These are marked as sponsored posts at the bottom of each post. For avoidance of any doubts and to make it easier for you to differentiate sponsored or non-sponsored articles or links, you may consider all articles on our site or all links to external websites as sponsored . Please note that some of the services or products which we talk about carry a high level of risk and may not be suitable for everyone. These may be complex services or products and we request the readers to consider this purely from an educational standpoint. The information provided on this website is general in nature. Global Banking & Finance Review expressly disclaims any liability without any limitation which may arise directly or indirectly from the use of such information.

On June 30, 2020, Tekla Healthcare Opportunities Fund paid a monthly distribution of $0.1125 per share. It is currently estimated that this distribution is derived from return of capital or other capital source. The composition of this and subsequent distributions may vary from month to month because it may be materially impacted by future realized gains and losses on securities. The aggregate of the net unrealized appreciation of portfolio securities and net realized losses on sale of securities is $68,916,621, of which $71,300,772 represents net unrealized appreciation of portfolio securities.

The following table sets forth the estimated amounts of the current distribution, paid on June 30, 2020, and the cumulative distributions paid this fiscal year-to-date from the following sources: net investment income, net realized short-term capital gains, net realized long-term capital gains, and return of capital or other capital source. The Fund estimates that it has distributed more than its income and net realized capital gains; therefore, a portion of your distribution may be a return of capital. A return of capital may occur, for example, when some or all of the money that you have invested in the Fund is paid back to you. A return of capital distribution does not necessarily reflect the Funds investment performance and should not be confused with ˜yield or ˜income. All amounts are expressed per common share.

 

Current Distribution

Percentage Breakdown of Current Distribution

Total Cumulative Distributions for the Fiscal Year to Date1

Percentage Breakdown of the Total Cumulative Distributions for the Fiscal Year to Date1

Net Investment Income

$0.0000

0

%

$0.0238

2

%

Net Realized ST Cap Gains

$0.0000

0

%

$0.0555

6

%

Net Realized LT Cap Gains

$0.0000

0

%

$0.0791

8

%

Return of Capital or Other Capital Source

$0.1125

100

%

$0.8541

84

%

TOTAL (per common share):

$0.1125

100

%

$1.0125

100

%

The table below includes information relating to the Funds performance based on its NAV for certain periods.

Average annual return at NAV for the period from May 31, 2015 through May 31, 2020

6.62%

 

Annualized current distribution rate expressed as a percentage of NAV as of May 31,2020

6.63%

 

Cumulative total return at NAV for the fiscal year, through May 31, 20202

13.92%

 

Cumulative fiscal year-to-date distribution rate expressed as a percentage of NAV as of May 31, 20201

4.97%

 

You should not draw any conclusions about the Funds investment performance from the amount of this distribution or from the terms of the Funds managed distribution policy.

The amounts and sources of distributions reported in this press release are only estimates and are not being provided for tax reporting purposes. The actual amounts and sources of the amounts for tax reporting purposes will depend upon the Funds investment experience during the remainder of its fiscal year and may be subject to changes based on tax regulations. The Fund will send you a Form 1099-DIV for the calendar year that will tell you how to report these distributions for federal income tax purposes.

Tekla Healthcare Opportunities Fund (NYSE:THQ) is a closed-end fund that invests in companies in the healthcare industry.

Tekla Capital Management LLC, the Funds investment adviser, is a Boston, MA based healthcare-focused investment manager with approximately $2.7 billion of assets under management as of March 31, 2020. Tekla also serves as investment adviser to Tekla Healthcare Investors (NYSE:HQH), Tekla Life Sciences Investors (NYSE:HQL) and Tekla World Healthcare Fund (NYSE:THW), closed-end funds that invest in companies in the healthcare and life sciences industries. Information regarding the Funds and Tekla Capital Management LLC can be found at www.teklacap.com.

Please contact Destra Capital Advisors, the Funds marketing and investor support services agent, at [email protected] or call (877) 855-3434 if you have any questions regarding THQ.

  1. The Funds current fiscal year began on October 1, 2019.
  2. Cumulative total return at NAV is the percentage change in the Funds NAV and includes all distributions and assumes the reinvestment of those distributions for the period of September 30, 2019 through May 31, 2020.

Destra Capital Advisors

(877) 855-3434

[email protected]